P

Vaxcyte
D

PCVX

88.540
USD
0.15
(0.17%)
مغلق
حجم التداول
43,136
الربح لكل سهم
-4
العائد الربحي
-
P/E
-19
حجم السوق
11,035,319,783
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AAPL
    AAPL
    -3.130
    (-1.37%)
    229.75 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    197.06 USD
    F
    F
    -0.060
    (-0.54%)
    11.015 USD
    GE
    GE
    -1.530
    (-0.86%)
    181.11 USD
    GOOGL
    GOOGL
    -3.110
    (-1.77%)
    164.75 USD
    MSFT
    MSFT
    -11.75
    (-2.75%)
    417.03 USD
    N
    NIO
    0.06500
    (1.47%)
    4.49500 USD
    N
    NKLA
    -0.07500
    (-3.12%)
    2.33000 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    352.65 USD
    المزيد
الأخبار

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.